NCT00078481View on ClinicalTrials.gov

Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

April 30, 2006

Conditions
Friedreich Ataxia
Interventions
DRUG

Idebenone

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00078481 - Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia | Biotech Hunter | Biotech Hunter